Cancer Cells Reprogram to Metastatic State Through the Acquisition of Platelet Mitochondria

Wenkan Zhang,Hao Zhou,Hengyuan Li,Haochen Mou,Eloy Yinwang,Yucheng Xue,Shengdong Wang,Yongxing Zhang,Zenan Wang,Tao Chen,Hangxiang Sun,Fangqian Wang,Jiahao Zhang,Xupeng Chai,Shixin Chen,Binghao Li,Changqing Zhang,Junjie Gao,Zhaoming Ye

DOI: https://doi.org/10.1016/j.celrep.2023.113464

IF: 8.8

2023-01-01

Cell Reports

Abstract:Metastasis is the major cause of cancer deaths, and cancer cells evolve to adapt to various tumor microenvironments, which hinders the treatment of tumor metastasis. Platelets play critical roles in tumor development, especially during metastasis. Here, we elucidate the role of platelet mitochondria in tumor metastasis. Cancer cells are reprogrammed to a metastatic state through the acquisition of platelet mitochondria via the PINK1/Parkin-Mfn2 pathway. Furthermore, platelet mitochondria regulate the GSH/GSSG ratio and reactive oxygen species (ROS) in cancer cells to promote lung metastasis of osteosarcoma. Impairing platelet mitochondrial function has proven to be an efficient approach to impair metastasis, providing a direction for osteosarcoma therapy. Our findings demonstrate mitochondrial transfer between platelets and cancer cells and suggest a role for platelet mitochondria in tumor metastasis.